Wikipedia:WikiProject Medicine/Cochrane/Cochrane Review List/Brain Nerves and Mind

Welcome Getting
Started WIKIPEDIAN
IN TRAINING RESOURCE Cochrane Reviews
on en.Wikipedia Cochrane Update
Project (english) Blogs Projects Cochrane Library Research Archive Questions

Cochrane Brain, Nerves and Mind Network:
Reviews to be considered for Wikipedia

Review Lists Updated: April 3 2020'

Common Mental Disorders Group

Updated oct 2024

2024-8 Repetitive transcranial magnetic stimulation for post-traumatic stress disorder in adults PMID undefined https://doi.org/10.1002/14651858.CD015040.pub2

2024-7 Cognitive behavioural therapy and third-wave approaches for anxiety and related disorders in older people PMID undefined https://doi.org/10.1002/14651858.CD007674.pub3

2024-6 Factors that influence participation in physical activity for people with bipolar disorder: a synthesis of qualitative evidence PMID undefined https://doi.org/10.1002/14651858.CD013557.pub2

2024-5 Early pharmacological interventions for prevention of post-traumatic stress disorder (PTSD) in individuals experiencing acute traumatic stress symptoms PMID 38767196 https://doi.org/10.1002/14651858.CD013613.pub2

2024-5 Psychological and social interventions for the promotion of mental health in people living in low- and middle-income countries affected by humanitarian crises PMID 38770799 https://doi.org/10.1002/14651858.CD014300.pub2

2024-3 Psychological therapies for depression in older adults residing in long-term care settings PMID 38501686 https://doi.org/10.1002/14651858.CD013059.pub2

2023-11 Pharmacological treatments in panic disorder in adults: a network meta-analysis PMID 38014714 https://doi.org/10.1002/14651858.CD012729.pub3

2023-8 Mental Health First Aid as a tool for improving mental health and well-being PMID 37606172 https://doi.org/10.1002/14651858.CD013127.pub2

2023-8 Specific psychological therapies versus other therapies or no treatment for severe and enduring anorexia nervosa PMID 37610143 https://doi.org/10.1002/14651858.CD011570.pub2

2021-12 Pre-deployment programmes for building resilience in military and frontline emergency service personnel PMID undefined https://doi.org/10.1002/14651858.CD013242.pub2

2021-5 Prognostic models for predicting relapse or recurrence of major depressive disorder in adults PMID undefined https://doi.org/10.1002/14651858.CD013491.pub2

2021-4 Psychosocial interventions for self-harm in adults PMID undefined https://doi.org/10.1002/14651858.CD013668.pub2

2021-4 Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults PMID undefined https://doi.org/10.1002/14651858.CD013495.pub2

2020-9 Means restriction for the prevention of suicide on roads PMID undefined https://doi.org/10.1002/14651858.CD013738

2020-8 Behavioural activation therapy for depression in adults with non-communicable diseases PMID undefined https://doi.org/10.1002/14651858.CD013461.pub2

2019-12 Pharmacy-based management for depression in adults PMID 31868236 https://doi.org/10.1002/14651858.CD013299.pub2

2019-11 Present-centered therapy (PCT) for post-traumatic stress disorder (PTSD) in adults PMID 31742672 https://doi.org/10.1002/14651858.CD012898.pub2

2019-3 Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease PMID 30838649 https://doi.org/10.1002/14651858.CD012347.pub2

2018-12 Psychological therapies for anxiety and depression in children and adolescents with long-term physical conditions PMID 30578633 https://doi.org/10.1002/14651858.CD012488.pub2

2018-12 Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease PMID 30566235 https://doi.org/10.1002/14651858.CD012346.pub2

2018-8 E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions PMID 30110718 https://doi.org/10.1002/14651858.CD012489.pub2

2018-8 Client feedback in psychological therapy for children and adolescents with mental health problems PMID 30124233 https://doi.org/10.1002/14651858.CD011729.pub2

2018-7 Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises PMID 29975811 https://doi.org/10.1002/14651858.CD011849.pub2

2017-3 Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease PMID 28322440 https://doi.org/10.1002/14651858.CD010673.pub2

2016-10 Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults PMID 27730622 https://doi.org/10.1002/14651858.CD011170.pub2

2016-7 Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults PMID 27409972 https://doi.org/10.1002/14651858.CD011119.pub2

2016-5 Psychosocial interventions for self-harm in adults PMID 27168519 https://doi.org/10.1002/14651858.CD012189

2016-4 Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder PMID 27040448 https://doi.org/10.1002/14651858.CD010204.pub2

2015-4 Debriefing interventions for the prevention of psychological trauma in women following childbirth PMID 25858181 https://doi.org/10.1002/14651858.CD007194.pub2

2014-11 Psychological, social and welfare interventions for psychological health and well-being of torture survivors PMID 25386846 https://doi.org/10.1002/14651858.CD009317.pub2

2014-11 Pharmacological interventions for somatoform disorders in adults PMID 25379990 https://doi.org/10.1002/14651858.CD010628.pub2

2014-10 Interventions for primary prevention of suicide in university and other post-secondary educational settings PMID 25353703 https://doi.org/10.1002/14651858.CD009439.pub2

2014-9 Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults PMID 25230088 https://doi.org/10.1002/14651858.CD009083.pub2

2014-9 Antidepressant treatment for postnatal depression PMID 25211400 https://doi.org/10.1002/14651858.CD002018.pub2

2013-10 Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder PMID 24132760 https://doi.org/10.1002/14651858.CD003196.pub2

2013-10 Enhanced care by generalists for functional somatic symptoms and disorders in primary care PMID 24142886 https://doi.org/10.1002/14651858.CD008142.pub2

2013-6 Tricyclic drugs for depression in children and adolescents PMID 23780719 https://doi.org/10.1002/14651858.CD002317.pub2

2012-12 Interventions to facilitate return to work in adults with adjustment disorders PMID 23235630 https://doi.org/10.1002/14651858.CD006389.pub2

2012-12 Tiagabine for acute affective episodes in bipolar disorder PMID 23235614 https://doi.org/10.1002/14651858.CD004694.pub3

2012-11 Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents PMID 23152246 https://doi.org/10.1002/14651858.CD007504.pub2

2011-12 Tiagabine in the maintenance treatment of bipolar disorder PMID 22161389 https://doi.org/10.1002/14651858.CD005173.pub3

2011-11 Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease PMID 22071851 https://doi.org/10.1002/14651858.CD008483.pub2

Dementia and Cognitive Improvement Group

Updated: Oct 2024 2024-8 Shunting for idiopathic normal pressure hydrocephalus PMID undefined https://doi.org/10.1002/14651858.CD014923.pub2

2024-5 Non-pharmacological interventions for improving language and communication in people with primary progressive aphasia PMID undefined https://doi.org/10.1002/14651858.CD015067.pub2

2023-11 Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) for the diagnosis of delirium in adults in critical care settings PMID 37987526 https://doi.org/10.1002/14651858.CD013126.pub2

2023-7 Interventions for preventing and reducing the use of physical restraints for older people in all long-term care settings PMID 37500094 https://doi.org/10.1002/14651858.CD007546.pub3

2023-6 Multi-domain prognostic models used in middle-aged adults without known cognitive impairment for predicting subsequent dementia PMID 37265424 https://doi.org/10.1002/14651858.CD014885.pub2

2022-4 Algorithm-based pain management for people with dementia in nursing homes PMID undefined https://doi.org/10.1002/14651858.CD013339.pub2

2022-4 Diagnostic test accuracy of remote, multidomain cognitive assessment (telephone and video call) for dementia PMID undefined https://doi.org/10.1002/14651858.CD013724.pub2

2021-12 Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia PMID undefined https://doi.org/10.1002/14651858.CD013304.pub2

2021-8 Enteral tube feeding for people with severe dementia PMID undefined https://doi.org/10.1002/14651858.CD013503.pub2

2021-7 Diagnostic test accuracy of telehealth assessment for dementia and mild cognitive impairment PMID undefined https://doi.org/10.1002/14651858.CD013786.pub2

2021-7 Mini-Cog for the detection of dementia within a primary care setting PMID undefined https://doi.org/10.1002/14651858.CD011415.pub3

2021-7 Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care setting PMID undefined https://doi.org/10.1002/14651858.CD010772.pub3

2021-7 Mini-Cog for the detection of dementia within a secondary care setting PMID undefined https://doi.org/10.1002/14651858.CD011414.pub3

2021-5 Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia PMID undefined https://doi.org/10.1002/14651858.CD004034.pub4

2021-2 Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting PMID undefined https://doi.org/10.1002/14651858.CD010945.pub2

2021-2 Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia PMID undefined https://doi.org/10.1002/14651858.CD009081.pub2

2020-12 Souvenaid for Alzheimer's disease PMID undefined https://doi.org/10.1002/14651858.CD011679.pub2

2020-3 Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment PMID undefined https://doi.org/10.1002/14651858.CD009628.pub2

2020-2 Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit PMID undefined https://doi.org/10.1002/14651858.CD012670.pub2

2019-3 Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife PMID 30864746 https://doi.org/10.1002/14651858.CD012278.pub2

2019-3 Computerised cognitive training for preventing dementia in people with mild cognitive impairment PMID 30864747 https://doi.org/10.1002/14651858.CD012279.pub2

2018-12 Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life PMID 30556597 https://doi.org/10.1002/14651858.CD011906.pub2

2018-12 Traditional Chinese herbal medicine for vascular dementia PMID 30520514 https://doi.org/10.1002/14651858.CD010284.pub2

2018-11 Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment PMID 30383288 https://doi.org/10.1002/14651858.CD011905.pub2

2018-7 Environmental and behavioural modifications for improving food and fluid intake in people with dementia PMID 30021248 https://doi.org/10.1002/14651858.CD011542.pub2

2018-6 Cholinesterase inhibitors for the treatment of delirium in non-ICU settings PMID 29952000 https://doi.org/10.1002/14651858.CD012494.pub2

2017-11 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID 29164600 https://doi.org/10.1002/14651858.CD012883

2017-11 18F PET with florbetapir for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID 29164603 https://doi.org/10.1002/14651858.CD012216.pub2

2017-11 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID 29164602 https://doi.org/10.1002/14651858.CD012884

2017-6 Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia PMID 28617932 https://doi.org/10.1002/14651858.CD003804.pub2

2017-4 Vitamin E for Alzheimer's dementia and mild cognitive impairment PMID 28418065 https://doi.org/10.1002/14651858.CD002854.pub5

2017-3 L-carnitine for cognitive enhancement in people without cognitive impairment PMID 28349514 https://doi.org/10.1002/14651858.CD009374.pub3

2016-9 Statin withdrawal in people with dementia PMID 27610945 https://doi.org/10.1002/14651858.CD012050.pub2

2016-1 Statins for the prevention of dementia PMID 26727124 https://doi.org/10.1002/14651858.CD003160.pub3

2015-9 Rivastigmine for Alzheimer's disease PMID 26393402 https://doi.org/10.1002/14651858.CD001191.pub4

2015-7 Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH) PMID 26222251 https://doi.org/10.1002/14651858.CD010033.pub2

2015-6 Regional Cerebral Blood Flow Single Photon Emission Computed Tomography for detection of Frontotemporal dementia in people with suspected dementia PMID 26102272 https://doi.org/10.1002/14651858.CD010896.pub2

2015-5 Opioids for agitation in dementia PMID 25972091 https://doi.org/10.1002/14651858.CD009705.pub2

2015-3 Cholinesterase inhibitors for rarer dementias associated with neurological conditions PMID 25734590 https://doi.org/10.1002/14651858.CD009444.pub3

2015-1 Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies PMID 25632881 https://doi.org/10.1002/14651858.CD010633.pub2

2014-6 Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID 24913723 https://doi.org/10.1002/14651858.CD008782.pub4

2014-2 Metal protein attenuating compounds for the treatment of Alzheimer's dementia PMID 24563468 https://doi.org/10.1002/14651858.CD005380.pub5

2013-8 Driving assessment for maintaining mobility and safety in drivers with dementia PMID 23990315 https://doi.org/10.1002/14651858.CD006222.pub4

2013-7 Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol PMID 23818100 https://doi.org/10.1002/14651858.CD004033.pub3

2013-5 Flow-regulated versus differential pressure-regulated shunt valves for adult patients with normal pressure hydrocephalus PMID 23728696 https://doi.org/10.1002/14651858.CD009706.pub2

2013-5 Rivastigmine for vascular cognitive impairment PMID 23728651 https://doi.org/10.1002/14651858.CD004744.pub3

2012-12 Huperzine A for mild cognitive impairment PMID 23235666 https://doi.org/10.1002/14651858.CD008827.pub2

2012-9 Cholinesterase inhibitors for mild cognitive impairment PMID 22972133 https://doi.org/10.1002/14651858.CD009132.pub2

2012-7 Hyperbaric oxygen therapy for vascular dementia PMID 22786527 https://doi.org/10.1002/14651858.CD009425.pub2

2012-6 Omega 3 fatty acid for the prevention of cognitive decline and dementia PMID 22696350 https://doi.org/10.1002/14651858.CD005379.pub3

2012-3 Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease PMID 22419314 https://doi.org/10.1002/14651858.CD006504.pub2

2012-2 Functional analysis-based interventions for challenging behaviour in dementia PMID 22336826 https://doi.org/10.1002/14651858.CD006929.pub2

2011-12 Naftidrofuryl for dementia PMID 22161372 https://doi.org/10.1002/14651858.CD002955.pub4

2011-3 Almitrine-Raubasine combination for dementia PMID 21412915 https://doi.org/10.1002/14651858.CD008068.pub2

Developmental, Psychosocial and Learning Problems Group

Updated Oct 2024

2024-1 Mindfulness-enhanced parenting programmes for improving the psychosocial outcomes of children (0 to 18 years) and their parents PMID 38197473 https://doi.org/10.1002/14651858.CD012445.pub2

2023-8 Vocabulary interventions for second language (L2) learners up to six years of age PMID 37531583 https://doi.org/10.1002/14651858.CD014890.pub2

2023-6 Acetylcholinesterase inhibitors for autistic spectrum disorders PMID 37267443 https://doi.org/10.1002/14651858.CD013851.pub2

2023-5 Interventions from pregnancy to two years after birth for parents experiencing complex post-traumatic stress disorder and/or with childhood experience of maltreatment PMID undefined https://doi.org/10.1002/14651858.CD014874.pub2

2023-4 Personalised interventions for subgroups of children with conduct problems PMID undefined https://doi.org/10.1002/14651858.CD012746.pub2

2023-2 Behavioural and cognitive-behavioural interventions for outwardly directed aggressive behaviour in people with intellectual disabilities PMID undefined https://doi.org/10.1002/14651858.CD003406.pub5

2022-11 Pharmacological interventions for people with borderline personality disorder PMID undefined https://doi.org/10.1002/14651858.CD012956.pub2

2022-10 Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis PMID undefined https://doi.org/10.1002/14651858.CD013648.pub2

2022-10 Splinting for the non-operative management of developmental dysplasia of the hip (DDH) in children under six months of age PMID undefined https://doi.org/10.1002/14651858.CD012717.pub2

2022-9 Crisis interventions for adults with borderline personality disorder PMID undefined https://doi.org/10.1002/14651858.CD009353.pub3

2022-9 Overall prognosis of preschool autism spectrum disorder diagnoses PMID undefined https://doi.org/10.1002/14651858.CD012749.pub2

2022-8 Memantine for autism spectrum disorder PMID undefined https://doi.org/10.1002/14651858.CD013845.pub2

2022-7 Child protection training for professionals to improve reporting of child abuse and neglect PMID undefined https://doi.org/10.1002/14651858.CD011775.pub2

2022-6 Non-pharmacological interventions for sleep promotion in hospitalized children PMID undefined https://doi.org/10.1002/14651858.CD012908.pub2

2022-4 Fortification of salt with iron and iodine versus fortification of salt with iodine alone for improving iron and iodine status PMID undefined https://doi.org/10.1002/14651858.CD013463.pub2

2021-10 Provision of folic acid for reducing arsenic toxicity in arsenic-exposed children and adults PMID undefined https://doi.org/10.1002/14651858.CD012649.pub2

2021-9 Non-pharmacological interventions for stuttering in children six years and younger PMID undefined https://doi.org/10.1002/14651858.CD013489.pub2

2021-9 Nutrition-specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews PMID undefined https://doi.org/10.1002/14651858.CD013092.pub2

2021-7 Bisphosphonate use in children with cerebral palsy PMID undefined https://doi.org/10.1002/14651858.CD012756.pub2

2021-5 Training healthcare providers to respond to intimate partner violence against women PMID undefined https://doi.org/10.1002/14651858.CD012423.pub2

2021-2 The effectiveness and adverse effects of D-cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder PMID undefined https://doi.org/10.1002/14651858.CD013457.pub2

2021-1 Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults PMID undefined https://doi.org/10.1002/14651858.CD013011.pub2

2020-12 Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age PMID undefined https://doi.org/10.1002/14651858.CD012875.pub2

2020-11 Mechanically assisted walking training for walking, participation, and quality of life in children with cerebral palsy PMID undefined https://doi.org/10.1002/14651858.CD013114.pub2

2020-7 Psychological interventions to foster resilience in healthcare students PMID undefined https://doi.org/10.1002/14651858.CD013684

2020-6 Cognitive-behavioural therapy (CBT) interventions for young people aged 10 to 18 with harmful sexual behaviour PMID undefined https://doi.org/10.1002/14651858.CD009829.pub2

2020-5 Psychological therapies for people with borderline personality disorder PMID undefined https://doi.org/10.1002/14651858.CD012955.pub2

2020-1 Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors PMID undefined https://doi.org/10.1002/14651858.CD012547.pub2

2019-12 Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis PMID 31801180 https://doi.org/10.1002/14651858.CD011260.pub2

2019-12 Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis PMID 31858595 https://doi.org/10.1002/14651858.CD011780.pub2

2019-5 Preventive lipid-based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health, nutrition, and developmental outcomes PMID 31046132 https://doi.org/10.1002/14651858.CD012611.pub3

2019-2 Effectiveness of provision of animal-source foods for supporting optimal growth and development in children 6 to 59 months of age PMID 30779870 https://doi.org/10.1002/14651858.CD012818.pub2

2018-11 Community-based supplementary feeding for food insecure, vulnerable and malnourished populations – an overview of systematic reviews PMID 30480324 https://doi.org/10.1002/14651858.CD010578.pub2

2018-10 Parent-mediated interventions for promoting communication and language development in young children with Down syndrome PMID 30321454 https://doi.org/10.1002/14651858.CD012089.pub2

2018-7 De-escalation techniques for managing non-psychosis induced aggression in adults PMID 30019748 https://doi.org/10.1002/14651858.CD012034.pub2

2018-7 Parent-mediated communication interventions for improving the communication skills of preschool children with non-progressive motor disorders PMID 30040119 https://doi.org/10.1002/14651858.CD012507.pub2

2018-5 Interventions for childhood apraxia of speech PMID 29845607 https://doi.org/10.1002/14651858.CD006278.pub3

2017-11 Point-of-use fortification of foods with micronutrient powders containing iron in children of preschool and school-age PMID 29168569 https://doi.org/10.1002/14651858.CD009666.pub2

2017-5 Family therapy for autism spectrum disorders PMID 28509404 https://doi.org/10.1002/14651858.CD011894.pub2

2017-3 Pharmacological interventions for recurrent abdominal pain in childhood PMID 28262913 https://doi.org/10.1002/14651858.CD010973.pub2

2015-10 Pharmacological interventions for cognitive decline in people with Down syndrome PMID 26513128 https://doi.org/10.1002/14651858.CD011546.pub2

2015-9 Clozapine for psychotic disorders in adults with intellectual disabilities PMID 26397173 https://doi.org/10.1002/14651858.CD010625.pub2

2015-7 Screening women for intimate partner violence in healthcare settings PMID 26200817 https://doi.org/10.1002/14651858.CD007007.pub3

2015-3 Non-speech oral motor treatment for children with developmental speech sound disorders PMID 25805060 https://doi.org/10.1002/14651858.CD009383.pub2

2015-1 Parent-infant psychotherapy for improving parental and infant mental health PMID 25569177 https://doi.org/10.1002/14651858.CD010534.pub2

2014-9 Centre-based day care for children younger than five years of age in low- and middle-income countries PMID 25254354 https://doi.org/10.1002/14651858.CD010543.pub2

2014-9 Centre-based day care for children younger than five years of age in high-income countries PMID 25247266 https://doi.org/10.1002/14651858.CD010544.pub2

2014-4 The WHO Health Promoting School framework for improving the health and well-being of students and their academic achievement PMID 24737131 https://doi.org/10.1002/14651858.CD008958.pub2

2014-3 Auditory-verbal therapy for promoting spoken language development in children with permanent hearing impairments PMID 24619508 https://doi.org/10.1002/14651858.CD010100.pub2

2013-8 Fundoplication versus postoperative medication for gastro-oesophageal reflux in children with neurological impairment undergoing gastrostomy PMID 23986351 https://doi.org/10.1002/14651858.CD006151.pub3

2013-7 Psychoanalytic/psychodynamic psychotherapy for children and adolescents who have been sexually abused PMID 23904184 https://doi.org/10.1002/14651858.CD008162.pub2

2013-6 Educational and skills-based interventions for preventing relationship and dating violence in adolescents and young adults PMID 23780745 https://doi.org/10.1002/14651858.CD004534.pub3

2013-6 Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency anaemia PMID 23744449 https://doi.org/10.1002/14651858.CD001444.pub2

2013-6 Specialist home-based nursing services for children with acute and chronic illnesses PMID 23771694 https://doi.org/10.1002/14651858.CD004383.pub3

2013-4 Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities PMID 23633366 https://doi.org/10.1002/14651858.CD009084.pub2

2012-12 Zinc supplementation for mental and motor development in children PMID 23235652 https://doi.org/10.1002/14651858.CD007991.pub2

2012-10 Interventions for oropharyngeal dysphagia in children with neurological impairment PMID 23076958 https://doi.org/10.1002/14651858.CD009456.pub2

2012-4 Intravenous secretin for autism spectrum disorders (ASD) PMID 22513913 https://doi.org/10.1002/14651858.CD003495.pub3

2012-3 Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents PMID 22419332 https://doi.org/10.1002/14651858.CD008372.pub2

2011-12 Intermittent iron supplementation for improving nutrition and development in children under 12 years of age PMID 22161444 https://doi.org/10.1002/14651858.CD009085.pub2

2011-12 Home-based child development interventions for preschool children from socially disadvantaged families PMID 22161419 https://doi.org/10.1002/14651858.CD008131.pub2

2011-11 Melatonin for non-respiratory sleep disorders in visually impaired children PMID 22071850 https://doi.org/10.1002/14651858.CD008473.pub2

2011-4 Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents PMID 21491402 https://doi.org/10.1002/14651858.CD007839.pub2

2011-3 Individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children PMID 21412881 https://doi.org/10.1002/14651858.CD002964.pub2

Drugs and Alcohol Group

Updated: Oct 2024

2024-4 Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy PMID 38682758 https://doi.org/10.1002/14651858.CD015042.pub2

2024-1 Disulfiram for the treatment of cocaine dependence PMID 38180268 https://doi.org/10.1002/14651858.CD007024.pub3

2023-12 Motivational interviewing for substance use reduction PMID 38084817 https://doi.org/10.1002/14651858.CD008063.pub3

2023-5 Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries PMID undefined https://doi.org/10.1002/14651858.CD013350.pub2

2022-5 Music therapy for people with substance use disorders PMID undefined https://doi.org/10.1002/14651858.CD012576.pub3

2021-10 Mindfulness-based interventions for substance use disorders PMID undefined https://doi.org/10.1002/14651858.CD011723.pub2

2021-3 Effectiveness of psychosocial interventions for reducing parental substance misuse PMID undefined https://doi.org/10.1002/14651858.CD012823.pub2

2020-11 Maintenance agonist treatments for opiate-dependent pregnant women PMID undefined https://doi.org/10.1002/14651858.CD006318.pub4

2019-11 Psychological interventions for co-occurring depression and substance use disorders PMID 31769015 https://doi.org/10.1002/14651858.CD009501.pub2

2019-3 Family-based prevention programmes for alcohol use in young people PMID 30888061 https://doi.org/10.1002/14651858.CD012287.pub2

2018-12 Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders PMID 30577083 https://doi.org/10.1002/14651858.CD011315.pub2

2018-12 Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users PMID 30521696 https://doi.org/10.1002/14651858.CD009269.pub4

2017-9 Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community-dwelling populations PMID 28944453 https://doi.org/10.1002/14651858.CD011479.pub2

2017-4 Supervised dosing with a long-acting opioid medication in the management of opioid dependence PMID 28447766 https://doi.org/10.1002/14651858.CD011983.pub2

2015-6 Pharmacological interventions for drug-using offenders PMID 26035084 https://doi.org/10.1002/14651858.CD010862.pub2

2015-4 Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions PMID 25835053 https://doi.org/10.1002/14651858.CD006037.pub3

2014-11 Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents PMID 25369459 https://doi.org/10.1002/14651858.CD010704.pub2

2014-6 Maintenance treatments for opiate-dependent adolescents PMID 24957634 https://doi.org/10.1002/14651858.CD007210.pub3

2014-4 Detoxification treatments for opiate dependent adolescents PMID 24777492 https://doi.org/10.1002/14651858.CD006749.pub3

2013-6 QTc interval screening for cardiac risk in methadone treatment of opioid dependence PMID 23787716 https://doi.org/10.1002/14651858.CD008939.pub2

2013-6 Media campaigns for the prevention of illicit drug use in young people PMID 23740538 https://doi.org/10.1002/14651858.CD009287.pub2

2013-6 Magnesium for alcohol withdrawal PMID 23740536 https://doi.org/10.1002/14651858.CD008358.pub2

2013-1 Pharmacological therapies for maintenance treatments of opium dependence PMID 23440817 https://doi.org/10.1002/14651858.CD007775.pub2

2012-12 Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse PMID 23235633 https://doi.org/10.1002/14651858.CD006747.pub2

2011-11 Mentoring adolescents to prevent drug and alcohol use PMID 22071836 https://doi.org/10.1002/14651858.CD007381.pub2

2011-10 Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence PMID 21975742 https://doi.org/10.1002/14651858.CD004147.pub4

2011-9 Universal family-based prevention programs for alcohol misuse in young people PMID 21901733 https://doi.org/10.1002/14651858.CD009308

2011-9 Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification PMID 21901695 https://doi.org/10.1002/14651858.CD005031.pub4

2011-8 Brief interventions for heavy alcohol users admitted to general hospital wards PMID 21833953 https://doi.org/10.1002/14651858.CD005191.pub3

2011-8 Oral substitution treatment of injecting opioid users for prevention of HIV infection PMID 21833948 https://doi.org/10.1002/14651858.CD004145.pub4

2011-5 Universal school-based prevention programs for alcohol misuse in young people PMID 21563171 https://doi.org/10.1002/14651858.CD009113

Epilepsy Group

Updated Oct 2024

2024-8 Cenobamate add-on therapy for drug-resistant focal epilepsy PMID undefined https://doi.org/10.1002/14651858.CD014941.pub2

2023-4 Perampanel add-on for drug-resistant focal epilepsy PMID undefined https://doi.org/10.1002/14651858.CD010961.pub2

2022-8 Felbamate add-on therapy for drug-resistant focal epilepsy PMID undefined https://doi.org/10.1002/14651858.CD008295.pub6

2022-7 Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy PMID undefined https://doi.org/10.1002/14651858.CD013136.pub2

2022-4 Care delivery and self-management strategies for children with epilepsy PMID undefined https://doi.org/10.1002/14651858.CD006245.pub5

2022-2 Clonazepam monotherapy for treating people with newly diagnosed epilepsy PMID undefined https://doi.org/10.1002/14651858.CD013028.pub3

2022-1 Rapid versus slow withdrawal of antiepileptic drugs PMID undefined https://doi.org/10.1002/14651858.CD005003.pub4

2021-12 Carisbamate add-on therapy for drug-resistant focal epilepsy PMID undefined https://doi.org/10.1002/14651858.CD012121.pub2

2021-11 Topiramate for juvenile myoclonic epilepsy PMID undefined https://doi.org/10.1002/14651858.CD010008.pub5

2021-11 Antiepileptic drugs for seizure control in people with neurocysticercosis PMID undefined https://doi.org/10.1002/14651858.CD009027.pub4

2021-9 Sulthiame monotherapy for epilepsy PMID undefined https://doi.org/10.1002/14651858.CD010062.pub3

2021-8 Chloral hydrate as a sedating agent for neurodiagnostic procedures in children PMID undefined https://doi.org/10.1002/14651858.CD011786.pub3

2021-6 Eslicarbazepine acetate add-on therapy for drug-resistant focal epilepsy PMID undefined https://doi.org/10.1002/14651858.CD008907.pub4

2021-5 Treatment of epilepsy for people with Alzheimer's disease PMID undefined https://doi.org/10.1002/14651858.CD011922.pub4

2021-5 Lacosamide add-on therapy for focal epilepsy PMID undefined https://doi.org/10.1002/14651858.CD008841.pub3

2021-4 Antidepressants for people with epilepsy and depression PMID undefined https://doi.org/10.1002/14651858.CD010682.pub3

2021-4 Transcranial magnetic stimulation for the treatment of epilepsy PMID undefined https://doi.org/10.1002/14651858.CD011025.pub3

2021-1 Gabapentin add-on treatment for drug-resistant focal epilepsy PMID undefined https://doi.org/10.1002/14651858.CD001415.pub4

2020-11 Pharmacological treatment for continuous spike-wave during slow wave sleep syndrome and Landau-Kleffner Syndrome PMID undefined https://doi.org/10.1002/14651858.CD013132.pub2

2020-11 Rufinamide add-on therapy for drug-resistant epilepsy PMID undefined https://doi.org/10.1002/14651858.CD011772.pub3

2020-10 Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy PMID undefined https://doi.org/10.1002/14651858.CD008312.pub4

2020-7 Zonisamide add-on therapy for focal epilepsy PMID undefined https://doi.org/10.1002/14651858.CD001416.pub5

2019-12 Intravenous immunoglobulins for epilepsy PMID 31792946 https://doi.org/10.1002/14651858.CD008557.pub4

2019-12 Losigamone add-on therapy for focal epilepsy PMID 31823350 https://doi.org/10.1002/14651858.CD009324.pub5

2019-10 Tiagabine add-on therapy for drug-resistant focal epilepsy PMID 31608990 https://doi.org/10.1002/14651858.CD001908.pub4

2019-10 Clobazam add-on therapy for drug-resistant epilepsy PMID 31638272 https://doi.org/10.1002/14651858.CD004154.pub5

2019-10 Topiramate add-on therapy for drug-resistant focal epilepsy PMID 31642054 https://doi.org/10.1002/14651858.CD001417.pub4

2019-8 Sulthiame add-on therapy for epilepsy PMID 31453633 https://doi.org/10.1002/14651858.CD009472.pub4

2019-6 Surgery for epilepsy PMID 31237346 https://doi.org/10.1002/14651858.CD010541.pub3

2019-6 Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review PMID 31233229 https://doi.org/10.1002/14651858.CD012065.pub3

2018-11 Subpial transection surgery for epilepsy PMID 30383287 https://doi.org/10.1002/14651858.CD008153.pub4

2018-10 Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review PMID 30350354 https://doi.org/10.1002/14651858.CD003615.pub4

2018-6 Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review PMID 29952431 https://doi.org/10.1002/14651858.CD001031.pub4

2017-10 The role of high-frequency oscillations in epilepsy surgery planning PMID 28981957 https://doi.org/10.1002/14651858.CD010235.pub3

2017-7 Deep brain and cortical stimulation for epilepsy PMID 28718878 https://doi.org/10.1002/14651858.CD008497.pub3

2017-2 Propofol versus thiopental sodium for the treatment of refractory status epilepticus PMID 28155226 https://doi.org/10.1002/14651858.CD009202.pub4

2016-8 Polyunsaturated fatty acid supplementation for drug-resistant epilepsy PMID 27536971 https://doi.org/10.1002/14651858.CD011014.pub2

2016-5 Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis PMID 27209627 https://doi.org/10.1002/14651858.CD010247.pub3

2016-2 Care delivery and self management strategies for adults with epilepsy PMID 26842929 https://doi.org/10.1002/14651858.CD006244.pub3

2015-12 Interventions for psychotic symptoms concomitant with epilepsy PMID 26690687 https://doi.org/10.1002/14651858.CD006118.pub3

2015-11 Vigabatrin versus carbamazepine monotherapy for epilepsy PMID 26580100 https://doi.org/10.1002/14651858.CD008781.pub3

2015-9 Non-pharmacological interventions for people with epilepsy and intellectual disabilities PMID 26355236 https://doi.org/10.1002/14651858.CD005502.pub3

2015-8 Pharmacological treatments for preventing epilepsy following traumatic head injury PMID 26259048 https://doi.org/10.1002/14651858.CD009900.pub2

2015-7 Neuropsychological and psychological interventions for people with newly diagnosed epilepsy PMID 26198593 https://doi.org/10.1002/14651858.CD011311.pub2

2015-6 Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms PMID 26086765 https://doi.org/10.1002/14651858.CD005222.pub3

2015-2 Early versus late antiepileptic drug withdrawal for people with epilepsy in remission PMID 25922863 https://doi.org/10.1002/14651858.CD001902.pub2

2014-9 Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes PMID 25190506 https://doi.org/10.1002/14651858.CD006779.pub2

2014-2 Psychological and behavioural treatments for adults with non-epileptic attack disorder PMID 24519702 https://doi.org/10.1002/14651858.CD006370.pub2

2013-6 Treatment of infantile spasms PMID 23740534 https://doi.org/10.1002/14651858.CD001770.pub3

2011-8 Antiepileptic drugs for treating seizures in adults with brain tumours PMID 21833969 https://doi.org/10.1002/14651858.CD008586.pub2

Movement Disorders Group

Updated: Oct 2024

2022-6 Interventions for preventing falls in Parkinson's disease PMID undefined https://doi.org/10.1002/14651858.CD011574.pub2

2021-4 Botulinum toxin type A versus anticholinergics for cervical dystonia PMID undefined https://doi.org/10.1002/14651858.CD004312.pub3

2020-7 GLP-1 receptor agonists for Parkinson's disease PMID undefined https://doi.org/10.1002/14651858.CD012990.pub2

2016-10 Botulinum toxin type A versus botulinum toxin type B for cervical dystonia PMID 27782297 https://doi.org/10.1002/14651858.CD004314.pub3

2016-7 Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease PMID 27425786 https://doi.org/10.1002/14651858.CD010916.pub2

2016-7 Speech therapy for children with dysarthria acquired before three years of age PMID 27428115 https://doi.org/10.1002/14651858.CD006937.pub3

2015-12 Alprazolam for essential tremor PMID 26638213 https://doi.org/10.1002/14651858.CD009681.pub2

2015-9 Treadmill training for patients with Parkinson's disease PMID 26363646 https://doi.org/10.1002/14651858.CD007830.pub4

2014-6 Physiotherapy for Parkinson's disease: a comparison of techniques PMID 24936965 https://doi.org/10.1002/14651858.CD002815.pub2

2013-9 Botulinum toxin for masseter hypertrophy PMID 24018587 https://doi.org/10.1002/14651858.CD007510.pub3

2012-8 Comparison of speech and language therapy techniques for speech problems in Parkinson's disease PMID 22895931 https://doi.org/10.1002/14651858.CD002814.pub2

2012-8 Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease PMID 22895930 https://doi.org/10.1002/14651858.CD002812.pub2

2011-11 Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies PMID 22071848 https://doi.org/10.1002/14651858.CD008454.pub2

2011-11 Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials PMID 22071852 https://doi.org/10.1002/14651858.CD008535.pub2

2011-11 Helicobacter pylori eradication for Parkinson's disease PMID 22071847 https://doi.org/10.1002/14651858.CD008453.pub2

Multiple Sclerosis and Rare Diseases of the CNS Group

Updated: Oct 2024

2024-9 Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis PMID undefined https://doi.org/10.1002/14651858.CD015443.pub2

2023-11 Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis PMID 38032059 https://doi.org/10.1002/14651858.CD012186.pub2

2023-9 Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis PMID 37681561 https://doi.org/10.1002/14651858.CD013606.pub2

2023-6 Alemtuzumab for multiple sclerosis PMID 37272540 https://doi.org/10.1002/14651858.CD011203.pub3

2021-11 Siponimod for multiple sclerosis PMID undefined https://doi.org/10.1002/14651858.CD013647.pub2

2021-11 Rituximab for people with multiple sclerosis PMID undefined https://doi.org/10.1002/14651858.CD013874.pub2

Neuromuscular Group

Updated: Oct 2024

2024-2 Treatments for Morton's neuroma PMID 38334217 https://doi.org/10.1002/14651858.CD014687.pub2

2024-2 Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy PMID 38353301 https://doi.org/10.1002/14651858.CD001797.pub4

2024-1 Surgical versus non-surgical treatment for carpal tunnel syndrome PMID 38189479 https://doi.org/10.1002/14651858.CD001552.pub3

2024-1 Alpha-lipoic acid for diabetic peripheral neuropathy PMID 38205823 https://doi.org/10.1002/14651858.CD012967.pub2

2023-2 Local corticosteroid injection versus placebo for carpal tunnel syndrome PMID undefined https://doi.org/10.1002/14651858.CD015148

2023-2 Methods for informing people with amyotrophic lateral sclerosis/motor neuron disease of their diagnosis PMID undefined https://doi.org/10.1002/14651858.CD007593.pub2

2023-2 Splinting for carpal tunnel syndrome PMID undefined https://doi.org/10.1002/14651858.CD010003.pub2

2022-12 Bioengineered nerve conduits and wraps for peripheral nerve repair of the upper limb PMID undefined https://doi.org/10.1002/14651858.CD012574.pub2

2022-1 Immunoglobulin for multifocal motor neuropathy PMID undefined https://doi.org/10.1002/14651858.CD004429.pub3

2021-12 Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline PMID undefined https://doi.org/10.1002/14651858.CD013720.pub3

2021-5 Non-drug therapies for the secondary prevention of lower limb muscle cramps PMID undefined https://doi.org/10.1002/14651858.CD008496.pub3

2021-5 Interventions for promoting physical activity in people with neuromuscular disease PMID undefined https://doi.org/10.1002/14651858.CD013544.pub2

2021-4 Cough augmentation techniques for people with chronic neuromuscular disorders PMID undefined https://doi.org/10.1002/14651858.CD013170.pub2

2020-1 Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome PMID undefined https://doi.org/10.1002/14651858.CD008630.pub5

2019-9 Respiratory muscle training in children and adults with neuromuscular disease PMID 31487757 https://doi.org/10.1002/14651858.CD011711.pub2

2019-3 Physical exercise training for type 3 spinal muscular atrophy PMID 30821348 https://doi.org/10.1002/14651858.CD012120.pub2

2018-12 Acupuncture for symptomatic gastroparesis PMID 30560568 https://doi.org/10.1002/14651858.CD009676.pub2

2018-10 Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy PMID 30326162 https://doi.org/10.1002/14651858.CD009068.pub3

2018-1 Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease PMID 29293261 https://doi.org/10.1002/14651858.CD011005.pub2

2017-12 Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders PMID 29199768 https://doi.org/10.1002/14651858.CD008380.pub2

2017-11 Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy PMID 29185258 https://doi.org/10.1002/14651858.CD002062.pub4

2017-8 Low-level laser therapy for carpal tunnel syndrome PMID 35611937 https://doi.org/10.1002/14651858.CD012765

2017-7 Immunotherapy for diabetic amyotrophy PMID 28746752 https://doi.org/10.1002/14651858.CD006521.pub4

2017-6 Drug therapy for chronic idiopathic axonal polyneuropathy PMID 28631805 https://doi.org/10.1002/14651858.CD003456.pub3

2017-5 Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy PMID 28481421 https://doi.org/10.1002/14651858.CD003280.pub5

2017-2 Plasma exchange for Guillain-Barré syndrome PMID 28241090 https://doi.org/10.1002/14651858.CD001798.pub3

2017-1 Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease PMID 28072907 https://doi.org/10.1002/14651858.CD011776.pub2

2017-1 Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease PMID 28067943 https://doi.org/10.1002/14651858.CD006049.pub2

2016-12 Antibiotics for the neurological complications of Lyme disease PMID 27931077 https://doi.org/10.1002/14651858.CD006978.pub2

2016-10 Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies PMID 27701752 https://doi.org/10.1002/14651858.CD002827.pub4

2016-8 Pharmacological treatments for Friedreich ataxia PMID 27572719 https://doi.org/10.1002/14651858.CD007791.pub4

2016-5 Corticosteroids for treating nerve damage in leprosy PMID 27210895 https://doi.org/10.1002/14651858.CD005491.pub3

2016-2 Rehabilitation following carpal tunnel release PMID 26884379 https://doi.org/10.1002/14651858.CD004158.pub3

2016-2 Interventions for dysphagia in long-term, progressive muscle disease PMID 26859621 https://doi.org/10.1002/14651858.CD004303.pub4

2015-12 Ascorbic acid for the treatment of Charcot-Marie-Tooth disease PMID 26662471 https://doi.org/10.1002/14651858.CD011952

2015-10 Surgery for scoliosis in Duchenne muscular dystrophy PMID 26423318 https://doi.org/10.1002/14651858.CD005375.pub4

2015-8 Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy PMID 26305459 https://doi.org/10.1002/14651858.CD003906.pub4

2015-6 Treatment for inclusion body myositis PMID 35658164 https://doi.org/10.1002/14651858.CD001555.pub5

2015-4 Quinine for muscle cramps PMID 25842375 https://doi.org/10.1002/14651858.CD005044.pub3

2015-3 Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy PMID 25739040 https://doi.org/10.1002/14651858.CD003217.pub5

2015-3 Treatment for IgG and IgA paraproteinaemic neuropathy PMID 25803231 https://doi.org/10.1002/14651858.CD005376.pub3

2015-3 Physical rehabilitation for critical illness myopathy and neuropathy PMID 25737049 https://doi.org/10.1002/14651858.CD010942.pub2

2014-12 Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders PMID 25503955 https://doi.org/10.1002/14651858.CD001941.pub3

2014-12 Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection PMID 25525951 https://doi.org/10.1002/14651858.CD010404.pub2

2014-12 Interventions for fatigue in peripheral neuropathy PMID 25519471 https://doi.org/10.1002/14651858.CD008146.pub2

2014-3 Interventions for preventing neuropathy caused by cisplatin and related compounds PMID 24687190 https://doi.org/10.1002/14651858.CD005228.pub4

2014-1 Interventions for preventing critical illness polyneuropathy and critical illness myopathy PMID 24477672 https://doi.org/10.1002/14651858.CD006832.pub3

2014-1 Endoscopic release for carpal tunnel syndrome PMID 24482073 https://doi.org/10.1002/14651858.CD008265.pub2

2013-12 Non-antiepileptic drugs for trigeminal neuralgia PMID 24297506 https://doi.org/10.1002/14651858.CD004029.pub4

2013-12 Immunotherapy for idiopathic lumbosacral plexopathy PMID 24379134 https://doi.org/10.1002/14651858.CD009722.pub2

2013-12 Mechanical insufflation-exsufflation for people with neuromuscular disorders PMID 24374746 https://doi.org/10.1002/14651858.CD010044.pub2

2013-10 Chinese herbal medicine for diabetic peripheral neuropathy PMID 24096743 https://doi.org/10.1002/14651858.CD007796.pub3

2013-6 Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease PMID 23740607 https://doi.org/10.1002/14651858.CD005226.pub3

2013-5 Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease PMID 23728653 https://doi.org/10.1002/14651858.CD005229.pub3

2013-3 Therapeutic ultrasound for carpal tunnel syndrome PMID 23543580 https://doi.org/10.1002/14651858.CD009601.pub2

2012-12 Treatment for paraneoplastic neuropathies PMID 23235647 https://doi.org/10.1002/14651858.CD007625.pub2

2012-12 Medical and surgical treatment for ocular myasthenia PMID 23235620 https://doi.org/10.1002/14651858.CD005081.pub3

2012-12 Decompressive surgery for treating nerve damage in leprosy PMID 23235638 https://doi.org/10.1002/14651858.CD006983.pub3

2012-12 Intravenous immunoglobulin for myasthenia gravis PMID 23235588 https://doi.org/10.1002/14651858.CD002277.pub4

2012-11 Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease PMID 23152212 https://doi.org/10.1002/14651858.CD002064.pub3

2012-8 Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis PMID 22895935 https://doi.org/10.1002/14651858.CD003643.pub4

2012-6 Exercise and mobilisation interventions for carpal tunnel syndrome PMID 22696387 https://doi.org/10.1002/14651858.CD009899

2012-6 Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome PMID 22696361 https://doi.org/10.1002/14651858.CD006828.pub3

2012-4 Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease PMID 22513921 https://doi.org/10.1002/14651858.CD004157.pub2

2012-2 Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease PMID 22336799 https://doi.org/10.1002/14651858.CD004156.pub4

2011-12 Physical training for McArdle disease PMID 22161416 https://doi.org/10.1002/14651858.CD007931.pub2

Schizophrenia Group

SEED Project Links

Schmidt et al 2017, Syst Rev: SEED: a tool for disseminating systematic review data into Wikipedia

• SEED tool home page: https://schizophrenia.cochrane.org/resources/resources-authors/systematic-evidence-dissemination-seed
• RCT protocol (ended August 2018) looking at impact of SEED: The effects of Wikipedia referencing: a protocol for a randomised trial.

Schizophrenia Group

Updated Oct 2024

2024-7 Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders PMID undefined https://doi.org/10.1002/14651858.CD013425.pub2

2024-5 Risk assessment for aggressive behaviour in schizophrenia PMID 38695777 https://doi.org/10.1002/14651858.CD012397.pub2

2024-5 Collaborative care approaches for people with severe mental illness PMID 38712709 https://doi.org/10.1002/14651858.CD009531.pub3

2024-3 Cognitive behavioural therapy added to standard care for first-episode and recent-onset psychosis PMID 38470162 https://doi.org/10.1002/14651858.CD015331.pub2

2024-2 Cognitive behavioural therapy without medication for schizophrenia PMID 38323679 https://doi.org/10.1002/14651858.CD015332.pub2

2023-7 Cognitive behavioural therapy plus standard care versus standard care for persistent aggressive behaviour or agitation in people with schizophrenia PMID 37490701 https://doi.org/10.1002/14651858.CD013511.pub2

2023-6 Magnetic seizure therapy for people with schizophrenia PMID 37272857 https://doi.org/10.1002/14651858.CD012697.pub2

2022-11 Antipsychotic dose reduction compared to dose continuation for people with schizophrenia PMID undefined https://doi.org/10.1002/14651858.CD014384.pub2

2022-10 Pharmacological interventions for prevention of weight gain in people with schizophrenia PMID undefined https://doi.org/10.1002/14651858.CD013337.pub2

2022-8 Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia PMID undefined https://doi.org/10.1002/14651858.CD014383.pub2

2022-7 Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms PMID undefined https://doi.org/10.1002/14651858.CD013100.pub2

2022-7 Cognitive behavioural therapy (group) for schizophrenia PMID undefined https://doi.org/10.1002/14651858.CD009608.pub2

2021-10 Parenting interventions for people with schizophrenia or related serious mental illness PMID undefined https://doi.org/10.1002/14651858.CD013536.pub2

2021-2 Video games for people with schizophrenia PMID undefined https://doi.org/10.1002/14651858.CD012844.pub2

2020-11 Specialised early intervention teams (extended time) for recent-onset psychosis PMID undefined https://doi.org/10.1002/14651858.CD013287.pub2

2019-8 Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses PMID 31425609 https://doi.org/10.1002/14651858.CD006570.pub3

2019-4 Haloperidol discontinuation for people with schizophrenia PMID 31006114 https://doi.org/10.1002/14651858.CD011408.pub2

2019-4 Yoga as part of a package of care versus non-standard care for schizophrenia PMID 30990224 https://doi.org/10.1002/14651858.CD012807.pub2

2018-10 Chlorpromazine versus piperacetazine for schizophrenia PMID 30378678 https://doi.org/10.1002/14651858.CD011709.pub2

2018-10 Occupational therapy delivered by specialists versus non-specialists for people with schizophrenia PMID 30293234 https://doi.org/10.1002/14651858.CD012398.pub2

2018-5 Increasing antipsychotic dose for non response in schizophrenia PMID 29750432 https://doi.org/10.1002/14651858.CD011883.pub2

2018-4 Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation) PMID 29634083 https://doi.org/10.1002/14651858.CD009412.pub2

2018-3 Cholinergic medication for antipsychotic-induced tardive dyskinesia PMID 29553158 https://doi.org/10.1002/14651858.CD000207.pub2

2018-2 Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia PMID 29409162 https://doi.org/10.1002/14651858.CD000459.pub3

2018-1 Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia PMID 29342497 https://doi.org/10.1002/14651858.CD000458.pub3

2018-1 Anticholinergic medication for antipsychotic-induced tardive dyskinesia PMID 29341071 https://doi.org/10.1002/14651858.CD000204.pub2

2018-1 Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse PMID 29355909 https://doi.org/10.1002/14651858.CD011057.pub2

2018-1 Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation) PMID 29308601 https://doi.org/10.1002/14651858.CD008074.pub2

2017-10 Different communication strategies for disclosing a diagnosis of schizophrenia and related disorders PMID 29064090 https://doi.org/10.1002/14651858.CD011707.pub2

2017-9 Chlorpromazine versus penfluridol for schizophrenia PMID 28940256 https://doi.org/10.1002/14651858.CD011831.pub2

2017-9 Yoga as part of a package of care versus standard care for schizophrenia PMID 28960019 https://doi.org/10.1002/14651858.CD012145.pub2

2017-6 Communication skills training for mental health professionals working with people with severe mental illness PMID 28613384 https://doi.org/10.1002/14651858.CD010006.pub2

2017-6 Clozapine dose for schizophrenia PMID 28613395 https://doi.org/10.1002/14651858.CD009555.pub2

2017-4 De-escalation techniques for psychosis-induced aggression or agitation PMID 28368091 https://doi.org/10.1002/14651858.CD009922.pub2

2017-4 Chlorpromazine versus clotiapine for schizophrenia PMID 28387925 https://doi.org/10.1002/14651858.CD011810.pub2

2017-4 Chlorpromazine dose for people with schizophrenia PMID 28407198 https://doi.org/10.1002/14651858.CD007778.pub2

2017-3 Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia PMID 28333365 https://doi.org/10.1002/14651858.CD006324.pub3

2017-1 Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness PMID 28116752 https://doi.org/10.1002/14651858.CD011464.pub2

2016-12 Droperidol for psychosis-induced aggression or agitation PMID 27976370 https://doi.org/10.1002/14651858.CD002830.pub3

2016-12 Implementation of treatment guidelines for specialist mental health care PMID 27977851 https://doi.org/10.1002/14651858.CD009780.pub3

2016-11 Haloperidol for long-term aggression in psychosis PMID 27889922 https://doi.org/10.1002/14651858.CD009830.pub2

2016-10 Bifeprunox versus placebo for schizophrenia PMID 27732740 https://doi.org/10.1002/14651858.CD012029.pub2

2016-9 Interventions to encourage uptake of cancer screening for people with severe mental illness PMID 27668891 https://doi.org/10.1002/14651858.CD009641.pub3

2016-9 HIV prevention advice for people with serious mental illness PMID 27609030 https://doi.org/10.1002/14651858.CD009639.pub3

2016-9 Oral health education (advice and training) for people with serious mental illness PMID 27606629 https://doi.org/10.1002/14651858.CD008802.pub3

2016-7 Fluphenazine (oral) versus atypical antipsychotics for schizophrenia PMID 27370402 https://doi.org/10.1002/14651858.CD010832.pub2

2016-6 Pharmacological interventions for clozapine-induced sinus tachycardia PMID 27277334 https://doi.org/10.1002/14651858.CD011566.pub2

2016-4 Chlorpromazine versus atypical antipsychotic drugs for schizophrenia PMID 27045703 https://doi.org/10.1002/14651858.CD010631.pub2

2016-4 Risperidone (depot) for schizophrenia PMID 27078222 https://doi.org/10.1002/14651858.CD004161.pub2

2016-3 Dietary advice for people with schizophrenia PMID 27007216 https://doi.org/10.1002/14651858.CD009547.pub2

2016-2 Antioxidant treatments for schizophrenia PMID 26848926 https://doi.org/10.1002/14651858.CD008919.pub2

2016-1 Smoking cessation advice for people with serious mental illness PMID 26816385 https://doi.org/10.1002/14651858.CD009704.pub2

2016-1 Antiglucocorticoid and related treatments for psychosis PMID 26725721 https://doi.org/10.1002/14651858.CD006995.pub2

2015-12 Crisis intervention for people with severe mental illnesses PMID 26633650 https://doi.org/10.1002/14651858.CD001087.pub5

2015-12 'As required' medication regimens for seriously mentally ill people in hospital PMID 26689942 https://doi.org/10.1002/14651858.CD003441.pub3

2015-12 Zuclopenthixol versus placebo for schizophrenia PMID 26624987 https://doi.org/10.1002/14651858.CD010598.pub2

2015-10 Yoga versus standard care for schizophrenia PMID 26488850 https://doi.org/10.1002/14651858.CD010554.pub2

2015-10 Lithium for schizophrenia PMID 26509923 https://doi.org/10.1002/14651858.CD003834.pub3

2015-10 Cognitive behavioural therapy (brief versus standard duration) for schizophrenia PMID 26488686 https://doi.org/10.1002/14651858.CD010646.pub3

2015-8 Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis PMID 26252640 https://doi.org/10.1002/14651858.CD011021.pub2

2015-6 Social skills programmes for schizophrenia PMID 26059249 https://doi.org/10.1002/14651858.CD009006.pub2

2015-5 Psychoeducation for siblings of people with severe mental illness PMID 25953641 https://doi.org/10.1002/14651858.CD010540.pub2

2015-2 Fluphenazine decanoate (depot) and enanthate for schizophrenia PMID 25654768 https://doi.org/10.1002/14651858.CD000307.pub2

2015-1 Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders PMID 25592299 https://doi.org/10.1002/14651858.CD009831.pub2

2014-10 Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia PMID 25290157 https://doi.org/10.1002/14651858.CD009369.pub2

2014-10 Virtual reality for treatment compliance for people with serious mental illness PMID 25300174 https://doi.org/10.1002/14651858.CD009928.pub2

2014-9 Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia PMID 25177834 https://doi.org/10.1002/14651858.CD009227.pub2

2014-7 Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia PMID 25007358 https://doi.org/10.1002/14651858.CD009268.pub2

2014-6 Information and communication technology based prompting for treatment compliance for people with serious mental illness PMID 24934254 https://doi.org/10.1002/14651858.CD009960.pub2

2014-6 Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders PMID 24915451 https://doi.org/10.1002/14651858.CD001470.pub2

2014-5 Horticultural therapy for schizophrenia PMID 24842458 https://doi.org/10.1002/14651858.CD009413.pub2

2014-3 General physical health advice for people with serious mental illness PMID 24676557 https://doi.org/10.1002/14651858.CD008567.pub3

2014-3 Family intervention (brief) for schizophrenia PMID 24595545 https://doi.org/10.1002/14651858.CD009802.pub2

2014-1 Length of hospitalisation for people with severe mental illness PMID 24477710 https://doi.org/10.1002/14651858.CD000384.pub3

2014-1 Physical health care monitoring for people with serious mental illness PMID 24442580 https://doi.org/10.1002/14651858.CD008298.pub3

2013-12 Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia PMID 24353163 https://doi.org/10.1002/14651858.CD009546.pub2

2013-10 User-held personalised information for routine care of people with severe mental illness PMID 24096715 https://doi.org/10.1002/14651858.CD001711.pub2

2013-10 Dance therapy for schizophrenia PMID 24092546 https://doi.org/10.1002/14651858.CD006868.pub3

2013-8 Haloperidol dose for the acute phase of schizophrenia PMID 23983042 https://doi.org/10.1002/14651858.CD001951.pub2

2013-7 Intermittent drug techniques for schizophrenia PMID 23881657 https://doi.org/10.1002/14651858.CD006196.pub2

2013-6 Preventive interventions for postnatal psychosis PMID 23740790 https://doi.org/10.1002/14651858.CD009991.pub2

2013-2 Training to recognise the early signs of recurrence in schizophrenia PMID 23450559 https://doi.org/10.1002/14651858.CD005147.pub2

2012-11 Bromperidol decanoate (depot) for schizophrenia PMID 23152208 https://doi.org/10.1002/14651858.CD001719.pub4

2012-10 Information and communication technology in patient education and support for people with schizophrenia PMID 23076932 https://doi.org/10.1002/14651858.CD007198.pub2

2012-6 Paliperidone palmitate for schizophrenia PMID 22696377 https://doi.org/10.1002/14651858.CD008296.pub2

2012-4 Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses PMID 22513898 https://doi.org/10.1002/14651858.CD000525.pub3

2012-2 Antipsychotic drug treatment for elderly people with late-onset schizophrenia PMID 22336800 https://doi.org/10.1002/14651858.CD004162.pub2

2011-12 Day hospital versus admission for acute psychiatric disorders PMID 22161384 https://doi.org/10.1002/14651858.CD004026.pub2

2011-6 Psychoeducation for schizophrenia PMID 21678337 https://doi.org/10.1002/14651858.CD002831.pub2

2011-6 Antipsychotic medication for early episode schizophrenia PMID 21678355 https://doi.org/10.1002/14651858.CD006374.pub2